Bisarylether Aromatic Molecules for Notch Pathway Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for pathological conditions such as cancer, skin disorders, and immune system-related disorders lack effective compounds that can inhibit cell growth, induce cell death, and modulate signaling pathways like the Notch pathway.

Innovation Solution

Development of novel bisarylether structures with specific aromatic cycles and substituents that exhibit antiproliferative and Notch signaling-enhancing activities, targeting conditions responsive to Notch regulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments are used for pathological conditions, then existing therapy options are available, but they lack effective compounds that can inhibit cell growth and induce cell death

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidability to inhibit cell growth and induce cell death
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by systematically varying the chemical structure of bisarylether compounds, specifically modifying the aromatic cycles and substituents at para-positions. This structural parameter optimization enables the compounds to achieve both high effectiveness in cell growth inhibition and versatility in targeting multiple pathological conditions including cancer and immune disorders

Inventive Principle:
Principle #35Parameter changes

2Reliability

If novel bisarylether structures with specific substituents are developed, then antiproliferative activity and Notch signaling enhancement are achieved, but the molecular complexity increases

Engineering Contradiction:
Improveantiproliferative activityVSAvoidmolecular structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies local quality by introducing specific functional groups at defined positions (para-positions) of the bisarylether core structure. The first substituent at the para-position of the benzyl ring and the second substituent at the para-position of the aryl ring are specifically designed with particular chemical properties, allowing the molecule to achieve high antiproliferative activity and Notch signaling enhancement while maintaining a systematic structural framework

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent applies composite materials by combining two aromatic cycles (benzyl ring and aryl ring) with specific substituents to create a composite molecular structure. This composite bisarylether architecture integrates different functional components that work synergistically to achieve both cell growth inhibition and Notch pathway modulation

Inventive Principle:
Principle #40Composite materials

3Productivity

If compounds targeting Notch signaling pathway are used, then cell growth inhibition and cell death induction are achieved, but the scope of applicable disorders needs to be validated

Engineering Contradiction:
Improvecell growth inhibition efficiencyVSAvoidapplicability to multiple disorders
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent applies universality by designing bisarylether compounds that can simultaneously target the Notch signaling pathway and achieve broad applicability across multiple disorder types. The compounds demonstrate multi-functionality by effectively treating not only cancer but also immune system-related disorders, skin disorders, and other pathological conditions, thereby validating their versatility beyond a single disease model

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250346549A2Novel aromatic molecules
Publication Date: 2025.11.13 XENIOPRO GMBH
  • US20250346549A2 patent drawing
  • US20250346549A2 patent drawing
  • US20250346549A2 patent drawing

AI summary

The present invention comprises novel aromatic molecules, which can be used in the treatment of pathological conditions, such as cancer, skin diseases, muscle disorders, and immune system-related disorders such as disorders of the haematopoietic system including the haematologic system in human and veterinary medicine.